AVALON PHARMA

Middle East Pharmaceutical Industries Company

4016StocksTadawulHealthcare

Overview

Market CapSAR 1.97B

Close PriceSAR 98.55

52-Week High / Low139.00 / 94.30

P/E (TTM)20.32

P/B4.74

EV/EBITDA16.79

Dividend Yield+3.7%

EPS (TTM)4.85

Book Value20.81

ROE+23.3%

Gross Margin+62.1%

Net Margin+21.1%

About

Middle East Pharmaceutical Industries Company engages in the research, development, manufacture, and marketing of generic medicines and pharmaceutical preparations in the Kingdom of Saudi Arabia and internationally.The company operates through three segments: Private, Public, and Export. Its product portfolio includes dermatological, respiratory, cardiovascular, alimentary and anti-infectives, musculoskeletal, genitourinary systems, and CNS.It exports its products. The company was formerly known as Middle East Chemical Products Factory Company and changed its name to Middle East Pharmaceutical Industries Company in January 2006.Middle East Pharmaceutical Industries Company was incorporated in 1998 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.

CEOMohammed Maher Al-Ghannam

Employees632

Founded1998

Fiscal Year EndJanuary - December

Website →

1 Week

+0.8%

1 Month

-12.2%

3 Months

-14.9%

6 Months

-21.3%

Year to Date

-11.4%

1 Year

-26.0%